Chatswood serves the life and health insurance sector in New Zealand with market intelligence, data, and bespoke consulting services. Some of these are provided in conjunction with Quality Product Research Limited - a subsidiary that brings you Quotemonster.
We believe that good decisions are more likely to occur when we have good information about the market environment in which we operate. Intuitive leaps and creative decisions are always required, of course, but the more they are based on a firm foundation of observation, the better they tend to be.
Swiss Re on emerging risk insights
Swiss Re’s SONAR 2025: New emerging risk insights report identifies new or changed risks that could impact on insurers today and in the future.
Swiss Re’s SONAR 2025: New emerging risk insights report identifies new or changed risks that could impact on insurers today and in the future. The report highlights a range of emerging risks, with those most relevant to the life and health insurance sector being: declining consumer trust in institutions and the insurance industry; elevated levels of excess mortality; aging populations; extreme heat events; fungi-adaptations; harm caused by plastics; new technologies in healthcare delivery; rising consumption of ultra-processed foods; workforce gaps and skillset shortages. It’s an interesting read - we’ve picked out some things we think are particularly relevant to the New Zealand market.
With aging populations, fewer and later family formations could lead to less events (such as the birth of a child) that typically spur life insurance purchases.
While NZ is not subject to such extremes of temperature as in other parts of the world, a recent study estimated that 500 children under five are hospitalised for heat-related reasons each year in NZ . Currently 14 heat-related deaths occur in Auckland’s over-65 population annually – with climate change increasing the number of days exceeding 25C, we can expect the number of people dying from heat-related deaths to increase correspondingly.
With fungi adapting to warmer temperatures and the overuse of fungicides leading to more multi-drug-resistant fungal pathogens, there could be an increase in fungal infections and limited medical treatment options for those with fungal infections.
The potential health effects from micro- and nano-plastics and their additives are still being studied, but there is growing research on the negative impacts of plastics on human health.
Swiss Re highlight that innovations like GLP-1 weight-loss medications and the increasing uptake of these drugs should help reduce mortality in the future. Semaglutide (Wegovy/Ozempic) was approved for weight-loss use in New Zealand by Medsafe last month, though it is not Pharmac-funded.
The increasing availability and variety of AI and virtual health services should lead to healthier populations over time, by enabling early detection and preventative interventions. Personalised health monitoring and nudges towards healthier behaviour (a la AIA’s vitality product) will potentially reduce claim frequencies and lead to longer healthspans. Conversely, the digitalisation of medical records and other previously private health information, comes with greater data security and privacy risks.
Research has shown associations between high consumption of ultra-processed foods and elevated health risks, including obesity, type-2 diabetes, depression, cardiovascular disease and cancer.
An aging workforce will contribute to labour and skillset shortages in the healthcare field, which could lead to delays in medical treatment, under-diagnosis and sub-standard levels of care – leading to an increase in morbidity and mortality. Healthcare worker shortages have been in the news regularly in NZ and The Royal NZ College of General Practitioner’s 2022 workforce survey found 64% of specialist GP’s were intending to retire by 2032.
More news:
Fidelity Life roll out this year’s annual product re-accreditation
Financial Advice NZ community of Practice: Central District 17 July
Scheme of Arrangement between Foundation Life and policyholders approved
Russell Hutchinson writes of how insurers could improve awareness
Australian advisers change fee structure, higher revenue and profit
‘Therapy’ chatbots lead to FTC complaint over unlicensed mental health advice
In the US, the Federal Trade Commission has received a complaint about Artificial Intelligence (AI) chatbots allegedly engaging in the ‘unlicensed practice of medicine’.
In the US, the Federal Trade Commission has received a complaint about Artificial Intelligence (AI) chatbots allegedly engaging in the ‘unlicensed practice of medicine’. A coalition of digital rights, consumer protection and mental health groups have submitted the complaint about Meta and Character.AI chatbots that purport to be mental health professionals. The complaint has also been submitted to Attorneys General and Mental Health Licensing Boards of all 50 states.
The complaint has two premises. First, that therapy bots had falsely claim to be licensed therapists with training, education, and experience - despite Meta and Character.AI’s terms of service, which claim to prohibit the use of Characters that purport to give advice in medical, legal, or otherwise regulated industries.
“In its complaint to the FTC, the Consumer Federation of America (CFA) found that even when it made a custom chatbot on Meta’s platform and specifically designed it to not be licensed to practice therapy, the chatbot still asserted that it was. “I'm licenced (sic) in NC and I'm working on being licensed in FL. It's my first year licensure so I'm still working on building up my caseload. I'm glad to hear that you could benefit from speaking to a therapist. What is it that you're going through?” a chatbot CFA tested said, despite being instructed in the creation stage to not say it was licensed. It also provided a fake license number when asked.”
And secondly, questions of confidentiality. Users have had millions of interactions with these bots, often divulging deeply personal circumstances, and the complaint asserts that confidentiality is repeatedly asserted. However, the companies' Terms of Use and Privacy Policies explicitly state interactions with the bot are not confidential, and that anything users input can be used for training and advertising purposes and sold to other companies.
More news:
Claire McArthur is moving to SHARE
Financial Advice NZ webinar 'CoFi Incentives Regulations- A FAP Perspective' 6 August
Financial Advice NZ 'Microbusiness Risk Management Course' 14 - 15 August
Financial Advice NZ session 'Wellington Women in Financial Advice' 24 July
Fidelity Life offers premium relief for severe weather-affected customers
Psilocybin being researched as treatment for clinical depression brain health and longevity
The Government announces the reestablishment of the Health New Zealand Board
FMA cancel FAP licence – advice process, record-keeping, disclosures, and evidence of suitability all factors
The Financial Markets Authority has cancelled Filcare Services Limited’s Financial Advice Provider licence, at its request.
Filcare held a full financial advice provider licence, and they provided financial advice to approximately 1,800 retail clients, many of whom were migrant workers from the Filipino community. Its cancellation follows the termination of its distribution agreement with Fidelity Life Assurance Company Limited and AIA New Zealand Limited and the FMA’s inquiry into its affairs.
Filcare were found to have contravened its licence obligations by failing to:
keep adequate records in relation to advice given to its clients,
ensure its clients understood the financial advice they received,
exercise care diligence and skill when providing financial advice to its clients,
provide adequate disclosures relating to advice, and
demonstrate that recommendations made to clients were suitable.
From our perspective, that appears to indicate failures in a wide range of areas of the advice process. As a comparison business we are particularly concerned with the areas of care, diligence, and skill, and demonstrating suitability – which we help more than 1,100 advisers with.
FMA’s Head of Perimeter and Response Helena Lewis said
“…we observed that clients did not receive adequate nature and scope disclosures and were therefore unable to make an informed decision about whether to seek, obtain, or act on the advice.
We also found that Filcare advisers failed to demonstrate that the recommendations made to clients were suitable. As an example, for a vast majority of clients, the documentation on file lacked the requisite detail to clearly show how the selected levels of cover were determined, and that the recommendation matched the risk tolerance, financial situation, and needs and goals of the client.
In files concerning replacement advice, there was no evidence that clients were informed of the potential risks of replacing existing policies, such as losing benefits they might have otherwise received under original policies, or the likelihood of exclusions or limitations associated with changes in health, lifestyle, or occupation that have occurred since the original policy has been taken out.”
Filcare clients with concerns are able to complain to Financial Services Complaints Limited.
More news:
Insurers see 'unprecedented' claims levels
Financial Advice NZ webinar '4S Framework for Effective Client Communication' 25 July
Westpac announce strategic agreement with POLi to bring secure open banking payments to NZers
ASB offer assistance to customers affected by severe weather
Pharmac and Medsafe to explore the utilisation of AI to speed up their processes
Munich Re look at how insurers can develop prevention strategies
Prevention is all about intervening before a disease or condition occurs – trying to extend the health span of peoples’ lives and prevent claims from arising in the first place. Munich Re’s Life Science Report looks at prevention strategies insurers can implement.
Munich Re’s Life Science Report 2025 has insights on global trends and risks that will shape the insurance industry over the next decade. We’ve written about their in-depth looks at AI in Healthcare and Improving Cancer Outcomes sections, and now we’re looking at their Prevention chapter.
Prevention is all about intervening before a disease or condition occurs – trying to extend the health span of peoples’ lives and prevent claims from arising in the first place.
In order to develop effective preventative strategies, insurers need a deep understanding of each of their clients’ unique characteristics, risk factors and health trends. Insurers should focus on areas where they’ll get the most bang for their buck, addressing lifestyle factors that contribute to the most significant preventable health risks and claims drivers – namely cardiovascular disease, cancer and mental health conditions. The key preventable causes for these are obesity, unhealthy diet, physical inactivity, smoking, excessive drinking and poor sleep patterns. Munich Re have a range of tables showing the impact of preventive measures on mortality, disability, critical illness and health care costs.
Munich Re categorise preventative health measures based on the stages of disease they are intended to prevent:
Primordial prevention - preventing development of risk factors for the entire population
Primary prevention - prevent onset of disease e.g. through lifestyle adjustments and medications
Secondary prevention - early diagnosis (e.g. through screening programmes) and prompt treatment
Tertiary prevention - manage existing disease to minimise complications and improve outcomes to prevent further morbidity and mortality
Quaternary prevention - protect from medical interventions that are likely to cause more harm than good.
To be effective, targeted interventions need to address an individual’s unique needs. By using personalised risk profiling, digital risk scores and advanced analytics, insurers can tailor interventions to maximise impact. To be efficient, insurers need to be able to amplify their prevention efforts to reach a wide audience and use digital systems to automate processes and incorporate real-time feedback. One of the most effective means of prevention is improving health literacy, the ability to navigate health information and make informed decisions. Munich Re suggest that informing policyholders about prevention benefits, enhancing health literacy, making things easy and incentivising members will all help drive positive health outcomes.
As we’ve already seen starting to occur here in NZ, insurers are positioning themselves as active participants in the well-being of their policyholders (with AIA’s Vitality programme perhaps the most notable example of this). We’d love to hear from you instances where your clients health insurance has led to them taking proactive steps to improve their health.
More news:
AIA employees return to newly renovated office space at AIA House in Smales Farm
AIA launch the third edition of Hikitia Mai, their Women in Leadership programme
Fidelity Life welcomes record number of advisers to Career Connect programme
Fidelity Life has announced the fourth intake of its adviser programme, Career connect, for new advisers and the recipients of their eight scholarships.
Fidelity Life has announced the fourth intake of its adviser programme, Career connect, for new advisers. This year sees the programme expand to welcome its largest cohort to date - 30 emerging advisers. The company will also soon invite adviser businesses to join the Career connect registry; to signal their interest in offering work experience opportunities to newly qualified financial advisers.
Submissions this year attracted greater diversity, , with 56% of applicants under the age of 35, 62% coming from female applicants and just under 30 ethnicities represented across the more than 70 applicants.
The Career connect programme awarded eight scholarships this year, up from seven last year, with each valued at up to $5,000. The recipients of the 2025 Career connect scholarships are:
Grace Leaso, Auckland - Kōwhai scholarship (for an outstanding Pasifika applicant)
Grace Shearer, Hastings - Toe Toe scholarship (for an outstanding young applicant aged 21-25)
Jada Mandery, Auckland - Women in Finance scholarship (supported by Kaplan Professional)
Marcel Stenning, Auckland - Pāua scholarship (for outstanding applicant demonstrating excellence)
Michelle Andrews, Auckland - Women in Finance scholarship (supported by Kaplan Professional)
Milly Elworthy, Mosgiel – Rural scholarship (supported by FMG)
Olivera Vasic-Wooller, Auckland - Rāngi Po scholarship (for an underrepresented community in financial services)
TK Buchanan, Christchurch - Pounamu scholarship (for an outstanding Māori applicant)
Fidelity Life Head of Solutions Michelle Doyle said
“By taking part, advice businesses play a vital role in mentoring fresh talent… It helps new advisers gain industry experience and build confidence as they transition into the profession.”
The 2025 cohort of 30 will start their journey this week. Over the next six months, they’ll take on part-time study to earn their Level 5 qualification through Kaplan Professional. Fidelity Life will host a graduation ceremony early next year to celebrate their accomplishments.
More news:
Financial Advice NZ Community of Practice: Christchurch 12 June
Introduction to Quotemonster webinar 9am, 27 May
Demystifying Advicemonster webinar 11am, 27 May
Business Risk Research and SOAs with Quotemonster webinar 12pm 29 May
Introduction to Kiwimonster webinar 12pm 26 May
Katrina Shanks and Kris Faafoi recognised on the Hot List 2025
Link Financial Group NZ appoints Anton Wicken new compliance manager
The banking industry welcomes the first reading of CCCFA amendment bill
New Zealanders will soon be able to receive 12-month prescriptions for their medicines
Legal and regulatory update for the life and health insurance sector
Amendments to Anti-Money Laundering and Countering Financing of Terrorism (AML/CFT) regime take effect on 1 June 2025; FMA to pilot a Financial Advice Regulatory Panel; RBNZ to launch Tara-ā-Umanga Business Expectations Survey on 21 May; the Credit Contracts and Consumer Finance Amendment Bill and the Financial Markets Conduct Amendment Bill had first readings in Parliament; RBNZ publish bulletin which discusses barriers Māori face in accessing capital.
8 May 2025 - A number of amendments to New Zealand's Anti-Money Laundering and Countering Financing of Terrorism (AML/CFT) regime are set to take effect on 1 June 2025. 3 Key Changes Impacting FAPs
Mandatory Customer Risk Rating
Enhanced Due Diligence for Low-Risk Trusts
Extended Reporting Timeframes
12 May 2025 - The FMA are to pilot a Financial Advice Regulatory Panel. The purpose of the Panel is to provide industry perspectives to the FMA on issues related to financial advice in New Zealand. The Panel will serve as a sounding board for how the FMA regulates the industry, including supporting good practice and ensure the FMA continue to regulate financial advice in a fit-for-purpose way. The FMA have approached key industry associations for nominations. https://www.linkedin.com/posts/financial-markets-authority-new-zealand_financialadvice-regulation-fma-activity-7327528052719083520-BD0y?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAwmg70BxdkhEtiDz1U0ui17rIBWTv3T_Es
14 May 2025 - On 21 May 2025 the RBNZ will be launching the Tara-ā-Umanga Business Expectations Survey (BES), publishing results for the June quarter.
14 May 2025 - The Credit Contracts and Consumer Finance Amendment Bill had its first reading in Parliament. https://bills.parliament.nz/v/6/6193a33c-40d6-4354-0d5a-08dd6ff875cc?Tab=history
14 May 2025 - The Financial Markets Conduct Amendment Bill had its first reading in Parliament. https://bills.parliament.nz/v/6/8c9fe069-724a-4200-0d58-08dd6ff875cc?Tab=history
15 May 2025 - The RBNZ has published a Bulletin article which discusses the barriers Māori face in accessing capital that may be associated with market failures or imperfections. https://www.rbnz.govt.nz/hub/news/2025/05/examining-maori-access-to-capital-market-failures
Munich Re look at improving Cancer outcomes
As part of Munich Re’s Life Science Report 2025, they have investigated the projected impact of advances in cancer treatment and research. These advances will change how cancers are defined, prevented, diagnosed and treated and are expected to significantly improve cancer mortality.
As part of Munich Re’s Life Science Report 2025, they have investigated the projected impact of advances in cancer treatment and research. These advances will change how cancers are defined, prevented, diagnosed and treated and are expected to significantly improve cancer mortality.
Cancer is the leading cause of death among policyholders for most insurers worldwide, as such it demands investigation. Much progress has been made in the past couple of decades to improve cancer mortality, through both reducing cancer risk factors (such as the dramatic downturn in tobacco use) and better diagnosis and treatment. Mortality improvement trends are expected to accelerate as our understanding of cancer genetics are combined with artificial intelligence (AI).
AI will be used to both improve cancer risk prevention and diagnostics. AI analysis of an individual’s personal information such as health data, family history, genetic and epigenetic profiles, microbiome, living environment and exposure history, sometimes called a statistical biopsy, will give a better understanding of risk for a wide range of cancers. This could potentially allow for a personalised approach to risks, behaviours, and identification of which strategies may be most effective in addressing these factors.
Being able to diagnose cancer more accurately, and at earlier stages, should improve cancer mortality. AI has already led to refinements in imaging studies, and in blood, urine and tissue samples. AI can also be used to analyse the tumour’s genetic pattern, other associated biomarkers and an individual’s risk profile to allow for better prognosis and management approach. AI’s ability to recognise patters not apparent to humans will help with diagnostic tools such as imaging studies, pathologic specimen interpretation and photograph analysis.
More effective screening approaches will lead to earlier cancer diagnosis and improved cancer mortality. An important technology, ‘liquid biopsy’, is currently used to analyse fluids to look for markers indicating the presence of a cancer, typically used to detect residual cancer after treatment or recurrence. If a liquid biopsy test that can screen for multiple cancers in asymptomatic individuals could be brought to market at a price point where it is accessible to the masses, it would be a game changer. Though it would also raise concerns about over-diagnosis and surveillance bias, as some identified cancers may never post a significant mortality risk.
The combination of AI and genomic analysis of tumour cells and immune cells has led to the development of targeted treatments that exploit specific genetic patterns. These treatments are more precise and safer than chemotherapy, with the four key categories of therapies emerging being targeted monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines and adoptive cell immunotherapy.
With potential changes in how cancers are classified, product definitions will need to be modified. Instead of being classified based on their tissue of origin, it’s expected new cancer tests will be able to categorise cancers based on their underlying genetic causes – potentially leading to thousands of cancer subtypes.
Where previously terminal cancers become able to be managed and instead turn into chronic disease, there may be implications for living benefits products. Reduced mortality should be favourable for life insurances businesses, though the costs of more sophisticated, individualised cancer treatments may have a negative cost impact on health insurance businesses. Munich Re predict that advances in diagnosis and changes in diagnostic criteria are going to increase cancer incidence rates in the short term, but may decrease critical illness rates if major advances in cancer prevention are realised.
AI will also have implications for underwriting. AI-based diagnosis is likely to be more accurate and predictive than current methods, with fewer false positive and false negative results, enabling risk to be better assessed. Better monitoring post-cancer treatment will mean recurrence risk can be more accurately assessed too.
More news:
Southern Cross Health Trust to fund salaries of nursing positions at City Missions
Kiwi advisers believe AI could help improve advice delivery
Pharmac to fund or widen access to three treatments, including for skin cancer, from 1 June 2025
Legal and regulatory update for the life and health insurance sector
The FMA publish takeaways from the CrowdStrike event survey; RBNZ publish response to submissions on core standards that set the prudential requirements deposit takers will need to meet in order to be licensed under the DTA; Cabinet designate banking as first sector under Customer and Product Data Act; Westpac is to pay a penalty of $3.25 million for misleading customers entitled to advertised discounts as well as overcharging some of its business customers; RBNZ special topic looks at how AI could impact financial stability; ASIC unveils digital portal for AFS licence applications; FSC publish KiwiSaver Industry Spotlight and Life Insurance Industry Spotlights for March 2025; The Credit Contracts and Consumer Finance Amendment Bill had its first reading and was referred to select committee; RBNZ release May Financial Stability Report; RBNZ change structure of its Executive Leadership Team.
29 Apr 2025 - The FMA have published key takeaways from the CrowdStrike event survey, which investigated how well financial service providers were prepared for and responded to the CrowdStrike incident. https://www.fma.govt.nz/library/research/key-takeaways-from-the-crowdstrike-event-survey/
1 May 2025 - The RBNZ has published its response to submissions on three of the four core standards that set the prudential requirements deposit takers will need to meet in order to be licensed under the Deposit Takers Act 2023 (DTA). The response covers liquidity, disclosure, and Depositor Compensation Scheme (DCS) related requirements. https://www.rbnz.govt.nz/hub/news/2025/05/reserve-bank-publishes-response-to-deposit-taker-core-standards-consultation
1 May 2025 - Cabinet has agreed to designate banking as the first sector under the Customer and Product Data Act. https://www.beehive.govt.nz/release/better-banking-competition-one-step-closer-kiwis
2 May 2025 - Westpac is to pay a penalty of $3.25 million for misleading customers entitled to advertised discounts as well as overcharging some of its business customers. Westpac admitted its conduct in civil proceedings brought by the FMA at the High Court in Auckland in December 2024. Westpac’s breaches of the fair dealing provisions under the Financial Markets Conduct Act 2013 (FMCA) affected a total of 24,621 customers and resulted in $6.35m in overcharges. https://www.fma.govt.nz/news/all-releases/media-releases/westpac-to-pay-3-25-million-penalty-for-misleading-customers/
5 May 2025 - The RBNZ publish a special topic from the May 2025 Financial Stability Report - Rise of the machines: How could artificial intelligence impact financial stability. https://www.rbnz.govt.nz/hub/news/2025/05/rise-of-the-machines-how-could-artificial-intelligence-impact-financial-stability
5 May 2025 - ASIC has unveiled a new digital portal to allow applicants to apply for an Australian financial services (AFS) licence. https://asic.gov.au/about-asic/news-centre/news-items/asic-launches-new-portal-for-australian-financial-services-licensees/
5 May 2025 - The FSC publish KiwiSaver Industry Spotlight March 2025. https://blog.fsc.org.nz/kiwisaver-spotlight-march-2025
5 May 2025 - The FSC publish Life Insurance Industry Spotlight March 2025. https://blog.fsc.org.nz/lifeinsurance-spotlight-march-2025
6 May 2025 - The Credit Contracts and Consumer Finance Amendment Bill had its first reading and was referred to select committee. https://bills.parliament.nz/v/6/6193a33c-40d6-4354-0d5a-08dd6ff875cc?Tab=history
7 May 2025 - Risks to the financial system have increased over the past six months, Reserve Bank Governor Christian Hawkesby says in releasing the May 2025 Financial Stability Report. https://www.rbnz.govt.nz/hub/news/2025/05/risks-to-the-financial-system-have-increased
7 May 2025 - The RBNZ is consolidating the structure of its Executive Leadership Team (ELT). The new ELT structure, which takes effect from Monday, 12 May 2025, is made up of four roles:
Assistant Governor Financial Stability
Assistant Governor Money Group
Assistant Governor Enterprise Services
Assistant Governor Operations
https://www.rbnz.govt.nz/hub/news/2025/05/rbnz-executive-leadership-team-changes
Proposed changes to Health and Safety Laws
We take a look at the proposed changes to Health and Safety laws, whereby the government wants to reduce compliance costs and provide greater certainty for businesses.
You may have seen the proposed changes to Health and Safety laws, whereby the government wants to reduce compliance costs and provide greater certainty for businesses. Bell Gully have a good summation of the proposed reforms here, but basically the Government is endeavouring to reduce the compliance burden, clarify health and safety duties (including limiting obligations for small, low-risk businesses) and clarify the distinction between governance and operational health and safety responsibilities.
There are many opposing points of view on the changes. Council of Trade Unions president Richard Wagstaff has said
"It's disappointing to see the minister has ignored the widespread consensus on what New Zealand needs to do to improve its poor track record and instead has chosen to carve out small businesses from good health and safety practices.
Exempting small businesses from best practice health and safety makes no sense when we know that small business are riskier and need more support."
Institute of Directors general manager Guy Beatson said
"Clarifying that boards are accountable for risk management and safety culture - not hands-on management - will mean directors can better focus on their core governance role without inadvertently overstepping."
Mike Cosman, chair of the Institute of Safety Management said
"The reforms are focused instead on costs to businesses of prevention and not the much greater costs of harm.
This seems to be looking through the wrong end of the telescope to us because the cost of our poor health and safety record is north of $4.9 billion per year to say nothing of the impact on workers and their families."
Russell Hutchinson has taken a look at the proposed regulations and put in his two cents.
As a country we have a not-terrible, but not-so-good track record on health and safety. One measure is fatal accidents, here I have selected countries we often use in comparisons:
Clearly, we are not as bad as, say, the United States. If we delved into that we would see significant variation on a state-by-state basis – but let’s not worry about that for now. Compared to Australia, for roughly every three people who die in a workplace accident there, four will die here. Not so good. What’s surprising is how well the UK performs – better than France and much of the EU, and better than Japan, places I normally consider to be better organised and more prescriptive in terms of employee protections. Not so! I like it when we find good data which challenges my pre-existing view. It’s a reward for paying attention to the data.
Are the proposed changes to governance liability right or wrong? One argument could be that by reducing liability on directors the workplace will become less safe. Another view is that by ensuring we place responsibility on the people who are closest to the problem we will better target the point at which better decisions can be made. Probably we will not know which until we have seen this operate for some time. Progress always seems to be so slow. Incentives also count – and the role of ACC, which has many benefits to our economy, also has some negative effects, somewhat masking the price signal in this case. I wonder if that will also get talked about.
More news:
Russell Hutchinson explains Non-Pharmac medicines coverage
AIA introducing a new excess option to AIA Private Health
AIA have updated Rules to Reinstate Policies
FSC Workplace Savings Half-Yearly Function 2025 is on 21 May
Financial Advice NZ are holding a 'Community of Practice: Central District' on 29 April
How to reduce chronic inflammation in your body
Eating well and getting regular exercise are most effective longevity tactics
Report finds deposit insurance scheme could see deposit interest rates fall significantly
Commerce Commission puts banks’ clawbacks, conversions and disincentives under scrutiny
AI becoming more trusted by executives
SAP investigated how US executives were using AI in their organisations and their trust in the technology.
SAP investigated how US executives were using AI in their organisations and their trust in the technology. They found that AI has become embedded in work practices (with 63% of executives using generative AI daily) and is changing how people do business.
Decisions are being made based on AI insights, with 44% of C-suite executives saying they would override a decision they had already planned to make based on AI insights and another 38% trusting AI to make business decisions on their behalf. 74% of executives had more confidence in AI advice over advice from family and friends. And a massive 55% of executives say in their company AI-driven insights have replaced or bypassed traditional decision-making.
Some common tasks carried out by generative AI tools include:
Analysing data and making recommendations for decision-making (52%)
Spotting risk or issues they hadn't previously considered (48%)
Offering alternate plans (47%)
Enhancing product development (40%)
Supporting budget planning (40%)
Performing market research (40%)
SAP found that there were positive implications on employee wellbeing, with 39% of executives reporting better work-life balance, 38% reporting improved wellbeing and 31% reporting reduced stress.
More news:
SortMe Advisor Portal, a tool designed to enhance financial advisory services, launches
AIA launch new Guide to Medical Underwriting
28% of large organisations rank AI-generated cyber threats as a major risk